CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for R-TECH UENO, LTD. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

R-TECH UENO, LTD.
10F
NBF Hibiya Bldg., 1-1-7, Uchisaiwai-cho
Phone: +81 335968011p:+81 335968011 CHIYODA-KU, TKY  100-0011  Japan Fax: +81 335968023f:+81 335968023
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
R-TECH UENO, LTD. is a Japan-based pharmaceutical company engaged in the development and sale of pharmaceutical products for the ophthalmological and dermatological diseases. The Company operates in three business segments. The New Active Research and Development segment is engaged in the development in unmet medical needs area, orphan drug area and anti-aging area. The Manufacture and Sales segment is mainly engaged in the manufacture and sale of Rescula Eye Drops for glaucoma and ocular hypertension. The Development Support and Contracted Manufacture Service segment is primarily engaged in the manufacture and sale of AMITIZA capsules for chronic idiopathic constipation. The Company is part of Sucampo Pharmaceuticals, Inc., which is owned by Mallinckrodt plc.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20153/31/2015Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Representative Director YukihikoMashima 60 6/1/2009 3/1/2004
Executive Officer, Chief Director of Research and Development KeizoHanada 7/1/2008 7/1/2008
Executive Officer, Director of Pharma Chemical Business RyuHirata
3 additional Officers and Directors records available in full report.

Business Names
Business Name
AMITIZA
R-TECH UENO, LTD.

General Information
Stock Exchange: TYO
Fax Number: +81 335968023


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023